Guidolin D D, Ronchetti I P, Lini E, Guerra D, Frizziero L
FIDIA Research Laboratories, Abano Terme, Italy.
Osteoarthritis Cartilage. 2001 May;9(4):371-81. doi: 10.1053/joca.2000.0398.
Histomorphometric study on cartilage samples taken from osteoarthritic human knees before and 6 months after intraarticular injections of a specific fraction (500-730 kDa) of hyaluronan. The results obtained with hyaluronan were compared with the results of methylprednisolone acetate treatment.
Twenty-four subjects with primary osteoarthritis (OA) of the knee were considered. Eleven patients were treated with Hyaluronan (Hyalgan), 20 mg/2 ml once a week for 5 weeks) and 13 with methylprednisolone (Depo-Medrol, 40 mg/1 ml once a week for 3 weeks). At the time of baseline and after 6 months from the start of treatment, biopsies of cartilage were taken and processed for electron microscopy. Articular surface morphology, territorial matrix, chondrocyte number and ultrastructure were characterized by a set of morphometric parameters. Samples from 19 informed patients showing no arthroscopic sign of OA were also used for comparison.
Six months after hyaluronan treatment a significant reconstitution of the superficial layer were observed together with an improvement in chondrocyte density and territorial matrix appearance. Furthermore, chondrocytes appeared significantly improved in their metabolism, as indicated by the increased extension of the synthetic structures and mitochondria with respect to the organelles having catabolic or storage functions. Hyaluronan treatment produced results that were significantly superior to those delivered with Methylprednisolone in almost all the morphometric estimators.
These results cannot be explained simply by temporary restoration of the synovial fluid viscoelasticity, and provide further evidence that the specific fraction of hyaluronan used in this study is a useful tool in OA treatment, with a potential structure-modifying activity.
对取自骨关节炎患者膝关节的软骨样本进行组织形态计量学研究,观察关节腔内注射特定分子量范围(500 - 730 kDa)透明质酸前及注射后6个月的情况。将透明质酸治疗的结果与醋酸甲基强的松龙治疗的结果进行比较。
纳入24例膝关节原发性骨关节炎(OA)患者。11例患者接受透明质酸(施沛特)治疗(20 mg/2 ml,每周1次,共5周),13例患者接受甲基强的松龙(得宝松,40 mg/1 ml,每周1次,共3周)治疗。在基线期及治疗开始后6个月时,采集软骨活检样本并进行电子显微镜处理。通过一组形态计量学参数对关节表面形态、局部基质、软骨细胞数量和超微结构进行表征。还使用了19例无OA关节镜表现的知情患者的样本进行比较。
透明质酸治疗6个月后,观察到表层有明显的重建,软骨细胞密度和局部基质外观有所改善。此外,软骨细胞的代谢明显改善,表现为合成结构和线粒体相对于具有分解代谢或储存功能的细胞器的延伸增加。在几乎所有形态计量学评估指标中,透明质酸治疗产生的结果均显著优于甲基强的松龙。
这些结果不能简单地用滑液粘弹性的暂时恢复来解释,进一步证明了本研究中使用的特定分子量范围的透明质酸是OA治疗的有用工具,具有潜在的结构修饰活性。